Clinical and Experimental Pharmacology and Physiology · 2018 · 42 citations · 15 references
Regulatory T (Treg) cells are critical suppressors of inflammation and are thought to exert mainly deleterious effects in cancers. In colorectal cancer (CRC), Foxp3<sup>+</sup> Treg accumulation in tumors was associated with poor prognosis. Hence, we examined the circulating Treg cells in CRC patients. Compared to controls, CRC patients presented mild upregulations in CD4<sup>+</sup> CD25<sup>+/hi</sup> T cells and in the more canonical CD4<sup>+</sup> CD25<sup>+/hi</sup> Foxp3<sup>+</sup> Treg cells in peripheral blood mononuclear cells. Both of these Treg populations could be roughly divided into lymphocyte activation gene 3 negative T cell immunoglobulin and mucin-domain containing-3 negative (LAG3<sup>-</sup> TIM3<sup>-</sup> ) and LAG3<sup>+</sup> TIM3<sup>+</sup> subsets. In CRC patients, the LAG3<sup>+</sup> TIM3<sup>+</sup> subset represented approximately half of CD4<sup>+</sup> CD25<sup>+/hi</sup> T cells and greater than 60% of CD4<sup>+</sup> CD25<sup>+/hi</sup> Foxp3<sup>+</sup> Treg cells, which was significantly more frequent than in healthy controls. Compared to the LAG3<sup>-</sup> TIM3<sup>-</sup> CD4<sup>+</sup> CD25<sup>+/hi</sup> T cells, the LAG3<sup>+</sup> TIM3<sup>+</sup> CD4<sup>+</sup> CD25<sup>+/hi</sup> T cells presented considerably higher transforming growth factor-β and slightly higher interleukin (IL)-10 secretion, together with higher cytotoxic T-lymphocyte associated protein 4 and Foxp3 expression levels. Notably, macrophages following incubation with LAG3<sup>-</sup> TIM3<sup>-</sup> CD4<sup>+</sup> CD25<sup>+/hi</sup> T cells and LAG3<sup>+</sup> TIM3<sup>+</sup> CD4<sup>+</sup> CD25<sup>+/hi</sup> T cells displayed different characteristics. Macrophages incubated with LAG3<sup>+</sup> TIM3<sup>+</sup> CD4<sup>+</sup> CD25<sup>+/hi</sup> T cells presented lower expression of major histocompatibility complex class II, CD80, CD86, and tumor necrosis factor-α but higher expression of IL-10, than macrophages incubated with LAG3<sup>-</sup> TIM3<sup>-</sup> CD4<sup>+</sup> CD25<sup>+/hi</sup> T cells. Together, our investigations demonstrated that CRC patients presented an enrichment of circulating Treg cells, in which the LAG3<sup>+</sup> TIM3<sup>+</sup> subset exhibited more potent expression of inhibitory molecules, and furthermore, the LAG3<sup>+</sup> TIM3<sup>+</sup> Treg cells could suppress the proinflammatory activation of macrophages more potently than the LAG3<sup>-</sup> TIM3<sup>-</sup> Treg cells.
15
Rebecca L. Siegel, Deepa Naishadham, Ahmedin Jemal · CA A Cancer Journal for Clinicians · 2013 · 11.9K citations · Full text
Lesley E. Smythies, Marty T. Sellers, Ronald H. Clements et al. · Journal of Clinical Investigation · 2005 · 786 citations
Human Intestinal Macrophages, Microbial Pathogens, Innate Immune System +19